RSV spread extends season as states expand immunization

The RSV spread immunization timeline is being extended across much of the United States as the virus continues circulating later into spring than usual.

Health officials are responding by widening access to preventive treatments for infants and young children.

RSV season lasts longer than expected

Respiratory syncytial virus typically peaks in winter and declines by early spring.

However, this year’s season has stretched beyond expectations.

Federal data shows that 7.5% of RSV tests were positive in mid-March—well above last year’s levels.

As a result, many states have extended immunization availability through the end of April.

Why RSV spread immunization is being extended

Health experts say the decision is driven by ongoing hospitalizations and emergency visits.

Dr. Susan Kansagra from the Association of State and Territorial Health Officials noted that RSV activity remains elevated in many regions.

Because RSV is the leading cause of infant hospitalization, extending protection is considered critical.

Monoclonal antibodies, which provide passive immunity, have been shown to significantly reduce severe illness in infants.

Infants remain the most vulnerable

According to the Centers for Disease Control and Prevention, two to three out of every 100 infants under three months are hospitalized with RSV each year.

This season alone, tens of thousands of children have already required hospital care.

The RSV spread immunization strategy aims to reduce these numbers by ensuring continued access to preventive treatments.

States expand access through April

Data from the Association of Immunization Managers shows that 48 jurisdictions have extended their RSV immunization programs through at least April 30.

This allows providers to continue administering antibody treatments through federal programs.

However, not all regions are following the same approach. Some states with year-round RSV activity or different data trends have chosen not to extend the timeline.

Immunization remains a key tool

Experts describe RSV immunizations as a major advancement in pediatric health.

In addition to antibody treatments for infants, vaccines are available during pregnancy to help protect newborns.

Recent studies show that these tools have already reduced RSV-related hospitalizations compared to previous seasons.

What’s driving the unusual RSV season

Researchers are still investigating why RSV spread has lasted longer this year.

Possible factors include:

• Changes in climate and seasonal patterns
• Variations in healthcare-seeking behavior
• Increased indoor exposure during certain periods

Experts emphasize that responses should be based on real-time data rather than fixed seasonal expectations.

Protecting infants remains the priority

The extended RSV spread immunization period reflects a broader shift toward data-driven public health strategies.

By adapting to current conditions, health officials aim to reduce hospitalizations and protect vulnerable populations.

As RSV continues circulating, maintaining access to immunization remains a critical step in safeguarding infant health.